Becton, Dickinson and Company (BDX) Competitors & Peers
The 5 largest companies in the same industry as Becton, Dickinson and Company, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ISRG | Peer | $405.18 | P/E 46.5RSI 63Cap 145.2 B |
| MDLN | Peer | $34.70 | P/E 43.4RSI 52Cap 30.4 B |
| ALC | Peer | $64.47 | P/E 49.2RSI 31Cap 31.2 B |
| RMD | Peer | $222.00 | P/E 21.3RSI 46Cap 32.0 B |
| WST | Peer | $370.44 | P/E 46.9RSI 63Cap 26.0 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- CAHSupplier
Cardinal Health distributes BD's medical devices and clinical products as a core wholesale and logistics channel for hospital networks.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MCKSupplier
McKesson is a primary distributor of BD's medical-surgical devices, consumables, and laboratory supplies to hospitals and clinics across North America.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- BAXCompetitor
Baxter competes directly with BD in the medication delivery and infusion systems markets (Baxter Spectrum infusion systems vs. BD Alaris).
Model-inferred, unverified — treat as a lead, not evidence - ICUICompetitor
ICU Medical competes with BD's infusion systems and vascular access device lines.
Model-inferred, unverified — treat as a lead, not evidence - WATMerger
Waters reverse-acquired BD Biosciences for $17.5B (closed 2025).
Model-inferred, unverified — treat as a lead, not evidence - WATPartner
Waters reverse-acquired BD Biosciences for $17.5B (closed 2025).
Model-inferred, unverified — treat as a lead, not evidence - OMCLCompetitor
Competes in global automated medication dispensing cabinet networks (BD Pyxis platforms).
Model-inferred, unverified — treat as a lead, not evidence - HOLXCompetitor
BD's Viper and BD Max molecular testing systems compete directly with Hologic's Panther platform and Aptima assay families in clinical laboratories.
Model-inferred, unverified — treat as a lead, not evidence - AMZNPartner
Becton Dickinson partners with AWS to host its BD Incada Connected Care Platform, which integrates medication management devices with hospital clinical workflows and cloud analytics.
Model-inferred, unverified — treat as a lead, not evidence - CORSupplier
Cencora serves as a major distributor for BD's clinical products, pharmaceutical delivery systems, and medical supplies.
Model-inferred, unverified — treat as a lead, not evidence - DGXCustomer
Quest Diagnostics is a major diagnostic laboratory customer that purchases BD Life Sciences' flow cytometers, BD COR molecular diagnostic instruments, and specimen collection consumables.
Model-inferred, unverified — treat as a lead, not evidence - LHCustomer
Labcorp is a primary diagnostic laboratory customer that runs routine and specialized pathology tests using BD's specimen tube systems and BD FACSLyric clinical flow cytometers.
Model-inferred, unverified — treat as a lead, not evidence - SOLVCompetitor
Both compete in medical fluid delivery and hospital consumables.
Model-inferred, unverified — treat as a lead, not evidence - LMATCompetitor
Both compete in vascular access and specialty surgical devices.
Model-inferred, unverified — treat as a lead, not evidence - DVASupplier
Becton Dickinson supplies advanced access needles and catheters used in hemodialysis clinic systems.
Model-inferred, unverified — treat as a lead, not evidence - LLYSupplier
Becton Dickinson supplies advanced needle technologies and pre-fillable syringe systems used in biologic auto-injectors.
Model-inferred, unverified — treat as a lead, not evidence - NVOSupplier
Becton Dickinson provides specialized injection components for Novo Nordisk's diabetes and obesity care units.
Model-inferred, unverified — treat as a lead, not evidence